1. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma
   Fei Wang et al, 2016, Oncotarget CrossRef
2. Simvastatin enhances the radiosensitivity of p53‑deficient cells via inhibition of mouse double minute 2 homolog
   Ji Lee et al, 2017, International Journal of Oncology CrossRef
3. A framework for identification of on- and off-target transcriptional responses to drug treatment
   Yi Huang et al, 2019, Scientific Reports CrossRef
4. Synergistic effect of receptor-interacting protein 140 and simvastatin on the inhibition of proliferation and survival of hepatocellular carcinoma cells
   Kun Xia et al, 2018, Oncology Letters CrossRef
5. Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG2 cells: An in vitro model of non-alcoholic fatty liver disease
   MOHAMMAD J. ALKHATATBEH et al, 2016, Experimental and Therapeutic Medicine CrossRef
6. Statins were not associated with hepatocellular carcinoma after controlling for time-varying confounders in patients with diabetes
   Yi-Chun Yeh et al, 2022, Journal of Clinical Epidemiology CrossRef
7. Lipid metabolism of hepatocellular carcinoma impacts targeted therapy and immunotherapy
   Xiao-Chen Feng et al, 2023, World Journal of Gastrointestinal Oncology CrossRef
8. Dysregulated cholesterol regulatory genes in hepatocellular carcinoma
   Dan Cao et al, 2023, European Journal of Medical Research CrossRef
9. Regulatory effects of statins on Akt signaling for prevention of cancers
   Fatemeh Sadat Hosseini et al, 2024, Cellular Signalling CrossRef
10. Protective role of microRNA‐374 against myocardial ischemia‐reperfusion injury in mice following thoracic epidural anesthesia by downregulating dystrobrevin alpha‐mediated Notch1 axis
    Zheng Zhao et al, 2019, Journal of Cellular Physiology CrossRef
11. Targeting SREBP-2-Regulated Mevalonate Metabolism for Cancer Therapy
    Linyuan Xue et al, 2020, Frontiers in Oncology CrossRef
12. Simvastatin Reduces Cancerogenic Potential of Renal Cancer Cells via Geranylgeranyl Pyrophosphate and Mevalonate Pathway
    Mathias Woschek et al, 2016, Nutrition and Cancer CrossRef
13. Cholesterol-Lowering Drugs on Akt Signaling for Prevention of Tumorigenesis
    Navneet Kumar et al, 2021, Frontiers in Genetics CrossRef
14. Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis
    Jiao Feng et al, 2020, Journal of Experimental & Clinical Cancer Research CrossRef